UK small-cap RNS · 30 Apr 2026

Anemoi International Ltd: Final Results For Year Ended 31 December 2025

CEO's Review on the Company Portfolio, Strategy and Operations

It is my pleasure to present the audited results for Aura Renewable Acquisitions Plc (the "Company" or "Aura") for the year ended 31 December 2025.

Technologies New Energy plc (LSE: TNE) (the "Company") announces the publication of its annual report and financial statements for the year ended 31 December 2025 ("Annual Report and Financial Statements"), which will be sent to the Financial Conduct …

Final results for the year ended 31 December 2025

Loss widened to £801k from £327k, book value per share fell to 16.9p from 20.5p and cash nearly halved to £447k, though admin costs fell and the Brislington sale deposit was retained.

Critical Mineral Resources PLC (‘CMR’, ‘CMRS’ or the ‘Company’), the exploration and development company focused on critical metals and minerals in Morocco is pleased to announce its audited results for the year ended 31 December 2025.

Synthomer plc (the "Company") has today published and submitted the annual report and accounts for the year ended 31 December 2025 for publication to the National Storage Mechanism in accordance with Listing Rule 6.4.1.

The Board of IBAI Ltd is pleased to announce the Company's audited financial statements for the year ended 31 December 2025.

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces its final audited results for the year ended 31 December 2025.

Final Results For Year Ended 31 December 2025

announces its audited final results for the year ended 31 December 2025.

("Grit" or the "Company" and, together with its subsidiaries, the "Group")

Audited Annual Results for the year ended December 31, 2025

Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases, is pleased to announce its final …

Chesterfield Resources / EPIC: CHF / Market: LSE / Sector: Mining

Audited results for the year ended 31 December 2025

AEP Plantations Plc will be holding its Annual General Meeting at the offices of UHY Hacker Young LLP, Quadrant House, Floor 6, 4 Thomas More Square, London E1W 1YW on Monday, 15 June 2026 at 11 am (UK time).

('Gulf Marine Services', 'GMS', 'the Company' or 'the Group')

Final Results for period to 31 December 2025

Availability of 2025 Annual Report and Notice of Annual General Meeting

Audited InvesCore FY25 shows profit up 21% and net interest income up 38%, but past due and NPL ratios roughly doubled, and the figures arrive after the audit delay and restatements.

Hamak Strategy Limited (LSE: HAMA / OTCQB: HASTF) a company combining traditional gold exploration in West Africa with a Digital Asset Treasury Management strategy, is pleased to announce its audited results for the period ended 31 December 2025.

FY2025 results largely restate drilling, metallurgy and corporate events already announced; they give no financials in the extract, so they add little new beyond the Board's proposal to exercise the Manna Hill option.

Final Assay Results Received Ahead of Maiden Beehive JORC Resource

Final Results for the year ended 31 December 2025

FY25 Adjusted EBITDA of £356.2m (+14%) matches the £355-360m guided in January, so profit is confirmed, not lifted. The £549.1m statutory loss comes from £440.3m of non-cash impairments after the UK duty rise.

FY2025 EBITDA of £136.5m matched expectations. Margin rose to 7.8% and free cash flow turned positive, but EBITDA and revenue fell and the statutory loss widened, so earnings did not grow.

Final audited FY25 confirm the January trading update: the cost base was cut and the adjusted EBITDA loss shrank to $0.74M, but revenue fell 3% and cash fell 27% to $1.9M.

Audited results for the year ended 31 December 2025

("Brave Bison" or the "Company", together with its subsidiaries "the Group")

Final results confirm FY25 revenue of £5.0m and a return to positive EBITDA, as flagged in January. Management expects 2026 revenue and EBITDA to rise, with Q1 revenue 5% ahead. This repeats the earlier message rather than raising guidance.

FY26 revenue guidance rises to £38.0m, but this was flagged on 16 April and largely reflects the £4.0m moved from FY25 by the new recognition policy. Adjusted EBITDA stays at £4.5m, with gross profit offset by £0.6m of expensed contract assets.

Paris, France, and Manchester, UK - 30 April 2026 - Novacyt S.A.

Another Record Year: Production up 17%, Revenue up 22% and Adjusted EBITDA up 56%

Adalan Ventures plc (the 'Company' or 'Adalan'), announces its audited annual results for the year ended 31 December 2025.

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan (the "Project"), announces its final results for the year ended 31 December 2025 ("FY25" or the "Period").

Final results for the year ended 31 December 2025

Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition company ("SPAC"), announces its audited results for the 12 months ended 31 December 2025.

Results restate the proposed pivot of the cash shell into Venezuelan energy with £1.6m of funding, but it still needs a general meeting and FCA approval of the prospectus. Going concern carries a material uncertainty.

Image Scan, (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets, today announces its interim results for the six months ended 31 March 2026.

Bay Capital Plc (LSE: BAY) has today published its Annual Report and Financial Statements for the period ended 31 December 2025 (the "Annual Report").

Pre-transaction shell reports a small loss of £167,089 with cash up to £209,224 after the 2025 Notes; the story turns on the IIG deal, not these numbers.

Final results for the year ended 31 December 2025

Order intake rose year on year and across the half, backed by large Ventilation project wins. This supports the stronger second half the Board expects, though no order book figure is given.